Quote For Endo Pharmaceuticals Holdings Inc ENDP.O
Endo Pharmaceuticals Holdings Inc (ENDP.O) (Nasdaq)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
--
--
--
$21.26
--
--
--
--
$26.14
$15.75
0.48
1,337,475
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Kimmel, Roger | Chairman of the Board | -- |
| Holveck, David | President, Chief Executive Officer, Director | 1,960,615 |
| Levin, Alan | Chief Financial Officer, Executive Vice President | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $2,492.93 |
| Shares Outstanding (Mil.) | 117.26 |
| Float (Mil.) | 115.10 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 2.85 |
| Current Ratio | 1.93 |
| LT Debt/Equity | 23.67 |
| Total Debt/Equity | 23.67 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 12.88 |
| Price/Sales(TTM) | 1.76 |
| Price/Book(TTM) | 1.85 |
| Price/Cash Flow(TTM) | 9.44 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $1.66 |
| Sales(TTM) | $12.08 |
| Book Value(MRQ) | $11.47 |
| Cash Flow(TTM) | $2.25 |
| Cash(MRQ) | $4.07 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 16.25 |
| Return on Assets(TTM) | 8.88 |
| Return on Investment(TTM) | 11.54 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 75.04 |
| Operating Margin(TTM) % | 24.26 |
| Profit Margin(TTM) % | 13.65 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
